Pooled Analysis of a Single IVIG 5% and 10% Product in Patients with Primary Immunodeficiency and Immune Thrombocytopenic Purpura

Monday, March 14, 2022

1:30pm – 3:00pm CT

KIM CLARK, PharmD, MBA, IgCP

Medical Affairs Director, US
Bio Products Laboratory
ME

Mark Evangelista, BS, MS

Senior Biostatistician
Atlantic Research Group
Eric Wolford, PharmD

Vice President, Global Medical
Bio Products Laboratory